Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	serine-type endopeptidase activity	PRSS3 PRSS8 CTRB2 KLK5 TLL1 TLL2 GZMB CTRB1 CTRL IMMP2L	4.53e-05	190	217	10	GO:0004252
GeneOntologyMolecularFunction	endopeptidase activity	PRSS3 PRSS8 ERAP1 CTRB2 CNTNAP5 CLCA1 KLK5 NRDC ADAMTS10 TLL1 TLL2 GZMB CTRB1 CTRL IMMP2L	7.72e-05	430	217	15	GO:0004175
GeneOntologyMolecularFunction	serine-type peptidase activity	PRSS3 PRSS8 CTRB2 KLK5 TLL1 TLL2 GZMB CTRB1 CTRL IMMP2L	9.28e-05	207	217	10	GO:0008236
GeneOntologyMolecularFunction	peptidase activity	PRSS3 PRSS8 ERAP1 CTRB2 ERMP1 CNTNAP5 CLCA1 KLK5 MYRF CPA5 NRDC ADAMTS10 TLL1 TLL2 GZMB CTRB1 CTRL CFAP44 IMMP2L	1.01e-04	654	217	19	GO:0008233
GeneOntologyMolecularFunction	serine hydrolase activity	PRSS3 PRSS8 CTRB2 KLK5 TLL1 TLL2 GZMB CTRB1 CTRL IMMP2L	1.13e-04	212	217	10	GO:0017171
GeneOntologyBiologicalProcess	regulation of serine-type peptidase activity	ANXA8L1 SEMG1 SEMG2 ANXA8	2.25e-06	10	214	4	GO:1902571
GeneOntologyBiologicalProcess	regulation of serine-type endopeptidase activity	ANXA8L1 SEMG1 SEMG2 ANXA8	2.25e-06	10	214	4	GO:1900003
MousePheno	abnormal direction of embryo turning	PKD1L1 PKD2 WDR35 MEGF8	1.20e-05	13	164	4	MP:0004190
Domain	WD_REPEATS_1	FBXW2 RACK1 TECPR2 WDR35 HERC2 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 PALB2 TLE3 UTP4 KCTD3 LRBA CFAP44	6.18e-10	278	216	19	PS00678
Domain	WD_REPEATS_2	FBXW2 RACK1 TECPR2 WDR35 HERC2 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 PALB2 TLE3 UTP4 KCTD3 LRBA CFAP44	6.56e-10	279	216	19	PS50082
Domain	WD_REPEATS_REGION	FBXW2 RACK1 TECPR2 WDR35 HERC2 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 PALB2 TLE3 UTP4 KCTD3 LRBA CFAP44	6.56e-10	279	216	19	PS50294
Domain	WD40_repeat	FBXW2 RACK1 TECPR2 WDR35 HERC2 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 TLE3 UTP4 KCTD3 LRBA CFAP44	2.97e-09	272	216	18	IPR001680
Domain	WD40_repeat_dom	FBXW2 RACK1 TECPR2 WDR35 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 PALB2 TLE3 UTP4 KCTD3 LRBA CFAP44	1.18e-08	297	216	18	IPR017986
Domain	WD40	FBXW2 RACK1 TECPR2 WDR35 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 TLE3 UTP4 KCTD3 LRBA CFAP44	1.56e-08	268	216	17	SM00320
Domain	-	FBXW2 RACK1 TECPR2 WDR35 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 PALB2 TLE3 UTP4 KCTD3 LRBA CFAP44	6.79e-08	333	216	18	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	FBXW2 RACK1 TECPR2 WDR35 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 PALB2 TLE3 UTP4 KCTD3 LRBA CFAP44	7.43e-08	335	216	18	IPR015943
Domain	WD40	FBXW2 RACK1 WDR35 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 TLE3 UTP4 LRBA CFAP44	3.64e-07	259	216	15	PF00400
Domain	CUB	CSMD2 CSMD3 ATRN CUBN MEGF8 TLL1 TLL2	1.43e-06	49	216	7	PF00431
Domain	CUB	CSMD2 CSMD3 ATRN CUBN MEGF8 TLL1 TLL2	1.64e-06	50	216	7	SM00042
Domain	-	CSMD2 CSMD3 ATRN CUBN MEGF8 TLL1 TLL2	2.16e-06	52	216	7	2.60.120.290
Domain	CUB	CSMD2 CSMD3 ATRN CUBN MEGF8 TLL1 TLL2	2.46e-06	53	216	7	PS01180
Domain	WD40_repeat_CS	FBXW2 RACK1 TBL1X GNB1L WDR5 WDR37 TBL1XR1 TBL3 TLE3 KCTD3 CFAP44	3.36e-06	164	216	11	IPR019775
Domain	CUB_dom	CSMD2 CSMD3 ATRN CUBN MEGF8 TLL1 TLL2	4.06e-06	57	216	7	IPR000859
Domain	G-protein_beta_WD-40_rep	FBXW2 RACK1 TBL1X WDR5 WDR37 TBL1XR1 TBL3	5.77e-05	85	216	7	IPR020472
Domain	Peptidase_S1_PA	PRSS3 PRSS8 CTRB2 KLK5 COX15 GZMB CTRB1 CTRL	9.27e-05	123	216	8	IPR009003
Domain	AnnexinVIII	ANXA8L1 ANXA8	1.33e-04	2	216	2	IPR009115
Domain	DUF1088	NBEA LRBA	1.33e-04	2	216	2	IPR010508
Domain	Semenogelin	SEMG1 SEMG2	1.33e-04	2	216	2	PF05474
Domain	Semenogelin	SEMG1 SEMG2	1.33e-04	2	216	2	IPR008836
Domain	DUF1088	NBEA LRBA	1.33e-04	2	216	2	PF06469
Domain	TRYPSIN_HIS	PRSS3 PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	1.94e-04	103	216	7	IPR018114
Domain	EGF_1	CNTNAP5 HEG1 ATRN LAMB4 FAT3 MUC12 CUBN MMRN1 MEGF8 TLL1 TLL2	1.96e-04	255	216	11	PS00022
Domain	EGF-type_Asp/Asn_hydroxyl_site	HEG1 FAT3 CUBN MMRN1 MEGF8 TLL1 TLL2	2.32e-04	106	216	7	IPR000152
Domain	TRYPSIN_SER	PRSS3 PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	2.32e-04	106	216	7	PS00135
Domain	TRYPSIN_HIS	PRSS3 PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	2.46e-04	107	216	7	PS00134
Domain	EGF_2	CNTNAP5 HEG1 ATRN LAMB4 FAT3 MUC12 CUBN MMRN1 MEGF8 TLL1 TLL2	2.72e-04	265	216	11	PS01186
Domain	Peptidase_S1A	PRSS3 PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	3.44e-04	113	216	7	IPR001314
Domain	Quinoprotein_ADH-like_supfam	FBXW2 TBL1X DMXL2 UTP4 ARHGAP27	3.61e-04	53	216	5	IPR011047
Domain	TRYPSIN_DOM	PRSS3 PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	3.83e-04	115	216	7	PS50240
Domain	TECPR	TECPR2 HERC2	3.96e-04	3	216	2	SM00706
Domain	BMP_1/tolloid-like	TLL1 TLL2	3.96e-04	3	216	2	IPR015446
Domain	Beta-propeller_rpt_TECPR	TECPR2 HERC2	3.96e-04	3	216	2	IPR006624
Domain	ANX	ANXA8L1 ANXA9 ANXA8	4.00e-04	13	216	3	SM00335
Domain	Annexin_repeat_CS	ANXA8L1 ANXA9 ANXA8	4.00e-04	13	216	3	IPR018252
Domain	Annexin	ANXA8L1 ANXA9 ANXA8	4.00e-04	13	216	3	PF00191
Domain	Annexin_repeat	ANXA8L1 ANXA9 ANXA8	4.00e-04	13	216	3	IPR018502
Domain	ANNEXIN	ANXA8L1 ANXA9 ANXA8	4.00e-04	13	216	3	PS00223
Domain	-	ANXA8L1 ANXA9 ANXA8	4.00e-04	13	216	3	1.10.220.10
Domain	Tryp_SPc	PRSS3 PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	4.25e-04	117	216	7	SM00020
Domain	EGF_CA	HEG1 FAT3 CUBN MEGF8 TLL1 TLL2	4.86e-04	86	216	6	PF07645
Domain	Annexin	ANXA8L1 ANXA9 ANXA8	5.05e-04	14	216	3	IPR001464
Domain	Trypsin_dom	PRSS3 PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	5.20e-04	121	216	7	IPR001254
Domain	Trypsin	PRSS3 PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	5.20e-04	121	216	7	PF00089
Domain	EGF_CA	HEG1 FAT3 CUBN MMRN1 MEGF8 TLL1 TLL2	5.47e-04	122	216	7	SM00179
Domain	EGF-like_Ca-bd_dom	HEG1 FAT3 CUBN MMRN1 MEGF8 TLL1 TLL2	6.02e-04	124	216	7	IPR001881
Domain	TRYPSIN_SER	PRSS8 CTRB2 KLK5 GZMB CTRB1 CTRL	6.20e-04	90	216	6	IPR033116
Domain	EGF_Ca-bd_CS	HEG1 FAT3 CUBN MEGF8 TLL1 TLL2	9.20e-04	97	216	6	IPR018097
Domain	EGF-like_CS	HEG1 ATRN LAMB4 FAT3 MUC12 CUBN MMRN1 MEGF8 TLL1 TLL2	9.53e-04	261	216	10	IPR013032
Domain	EGF_CA	HEG1 FAT3 CUBN MEGF8 TLL1 TLL2	1.02e-03	99	216	6	PS01187
Domain	DUF4704	NBEA LRBA	1.30e-03	5	216	2	IPR031570
Domain	DUF4704	NBEA LRBA	1.30e-03	5	216	2	PF15787
Domain	PH	CNKSR1 ARHGEF16 SPTBN5 AFAP1L2 OSBPL11 OSBPL10 ARAP2 ARHGAP27 FGD6	1.43e-03	229	216	9	PF00169
Domain	EGF	CNTNAP5 HEG1 ATRN FAT3 CUBN MMRN1 MEGF8 TLL1 TLL2	1.70e-03	235	216	9	SM00181
Domain	EGF_3	CNTNAP5 HEG1 ATRN FAT3 CUBN MMRN1 MEGF8 TLL1 TLL2	1.70e-03	235	216	9	PS50026
Domain	PH_BEACH	NBEA LRBA	1.94e-03	6	216	2	PF14844
Domain	Peptidase_M12A	TLL1 TLL2	1.94e-03	6	216	2	IPR001506
Domain	Astacin	TLL1 TLL2	1.94e-03	6	216	2	PF01400
Pathway	REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES	PRSS3 CTRB2 CUBN CTRB1	3.43e-06	10	163	4	M45024
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SIGMAR1 PFKFB1 ARHGEF16 SLC30A4 ITFG1 TMCO4 BPTF PTPRB FAM120A TECPR2 SYNJ2 ABCC8 PKD2 HSD11B2 TBL1X FAM149A SLC37A1 ATRN CARMIL1 FAM117B GRIK2 ZSWIM6 WDR37 TBL1XR1 KIAA1671 TLE3 TLL1 ANKRD17 LSS LRBA IMMP2L GPA33 TMEM63A	6.26e-10	1489	224	33	28611215
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	SMG1 TBRG4 SPART ITFG1 TMCO4 AFAP1L2 SYNJ2 TNRC6A OSBPL11 HERC2 MYRF NELFA SYNE1 TBL1XR1 TMEM38B KIAA1671 LRBA KIF13A FGD6	2.54e-07	719	224	19	35337019
Pubmed	Loss of chymotrypsin-like protease (CTRL) alters intrapancreatic protease activation but not pancreatitis severity in mice.	CTRB2 CTRB1 CTRL	2.64e-07	3	224	3	32678161
Pubmed	Secretagogue-induced pancreatitis in mice devoid of chymotrypsin.	CTRB2 CTRB1 CTRL	2.64e-07	3	224	3	38981616
Pubmed	ORP10, a cholesterol binding protein associated with microtubules, regulates apolipoprotein B-100 secretion.	OSBPL11 OSBPL10 APOB	1.05e-06	4	224	3	22906437
Pubmed	Chromosomal assignments of genes for trypsin, chymotrypsin B, and elastase in mouse.	PRSS3 CTRB2 CTRB1	2.61e-06	5	224	3	6589791
Pubmed	Genetic and biochemical characterization of a new chymotrypsin isozyme of the house mouse, CTRA-1.	CTRB2 CTRB1 CTRL	2.61e-06	5	224	3	1820020
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ARHGEF16 KIAA0753 BRAF SYNJ2 SVIL NAV2 OSBPL10 ARAP2 NELFE CARMIL1 MAP3K14 FAM117B PTPN21 NCKAP5L KIAA1671 MEGF8 ANKRD17 KIF13A FGD6	3.63e-06	861	224	19	36931259
Pubmed	Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.	PRSS3 CTRB2 CTRB1	5.20e-06	6	224	3	23814066
Pubmed	Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice.	PRSS3 CTRB2 SI LCT CTRB1	6.57e-06	41	224	5	23676500
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	SSBP1 CSMD3 RACK1 HERC2 NBPF14 NBPF8 CPA5 PIWIL4 APOB NBPF11 PALB2 NBPF10 SNRNP200 BMP15	7.00e-06	513	224	14	25798074
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF14 NBPF8 NBPF11 NBPF10	9.20e-06	21	224	4	16079250
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	BPTF FASN BRAF SVIL OSBPL11 ANXA9 PRRC2A NELFE NELFA CARMIL1 PALB2 PITPNM1 TLE3 GZMB ANKRD17 SNRNP200 CDH17	1.27e-05	774	224	17	15302935
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SMG1 ERAP1 WDR35 NAV2 DMXL2 SYNE1 ADGRA2 PRDM16 SNRNP200	1.69e-05	225	224	9	12168954
Pubmed	Identification and characterization of the potential promoter regions of 1031 kinds of human genes.	STXBP2 HERC2 TOR1A LY75 CDH17	2.15e-05	52	224	5	11337467
Pubmed	The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2.	ITGA2 ARHGEF16 AFAP1L2 BRAF NECTIN1 NAV2 OSBPL10 MYRF ARAP2 CARMIL1 APOB IFNGR1 LRBA FGD6	2.21e-05	569	224	14	30639242
Pubmed	Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.	PFKFB1 GFUS RACK1 TNRC6A NAV3 NAV2 ANXA9 SEMG1 SEMG2 NAGK NRDC ANXA8 TBL3 PRKRA KIAA1671 ANKRD17	2.44e-05	732	224	16	34732716
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	CNKSR1 TBRG4 FASN FAM120A BRAF OSBPL11 NAV2 PRRC2A NELFE NELFA TLE3 TMEM131 KIF13A	2.63e-05	503	224	13	16964243
Pubmed	RNF8/UBC13 ubiquitin signaling suppresses synapse formation in the mammalian brain.	SSBP1 HERC2 NEURL4	3.06e-05	10	224	3	29097665
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	SPART SSBP1 LCMT2 KIAA0753 FAM120A MRPS17 VPS13A HERC2 CARS2 ATPAF1 DMXL2 SYNE1 GNB1L TOR1A COX15 NCKAP5L TBL3 MTIF2 UTP4 MRPS5 LSS TMEM131 SNRNP200 NEURL4	3.65e-05	1487	224	24	33957083
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	TBRG4 SSBP1 SPTBN5 FAM120A MRPS17 VPS13A OSBPL11 HERC2 CARS2 MCUB BCL2L13 ATPAF1 SLC25A24 PDSS2 SYNE1 COX15 TMEM38B TBL3 KIAA1671 MTIF2 UTP4 MRPS5 TMEM131 NEURL4	4.02e-05	1496	224	24	32877691
Pubmed	TaqI polymorphisms at the annexin VIII locus (ANX8).	ANXA8L1 ANXA8	4.13e-05	2	224	2	1364010
Pubmed	Integrin α2 promotes immune escape in non-small-cell lung cancer by enhancing PD-L1 expression in exosomes to inhibit CD8 + T-cell activity.	ITGA2 CD274	4.13e-05	2	224	2	37804164
Pubmed	Herpes simplex virus glycoprotein D can bind to poliovirus receptor-related protein 1 or herpesvirus entry mediator, two structurally unrelated mediators of virus entry.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	9696799
Pubmed	The CTRB1-CTRB2 risk allele for chronic pancreatitis discovered in European populations does not contribute to disease risk variation in the Chinese population due to near allele fixation.	CTRB2 CTRB1	4.13e-05	2	224	2	28951524
Pubmed	Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARγ specifies lipid storage versus thermogenic gene programs.	TLE3 PRDM16	4.13e-05	2	224	2	23473036
Pubmed	Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis.	CTRB2 CTRB1	4.13e-05	2	224	2	28754779
Pubmed	Cyst formation in kidney via B-Raf signaling in the PKD2 transgenic mice.	BRAF PKD2	4.13e-05	2	224	2	19098310
Pubmed	ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5).	SLC27A5 APOB	4.13e-05	2	224	2	21826528
Pubmed	Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes.	ANXA8L1 ANXA8	4.13e-05	2	224	2	29306076
Pubmed	PRSS3/Mesotrypsin and kallikrein-related peptidase 5 are associated with poor prognosis and contribute to tumor cell invasion and growth in lung adenocarcinoma.	PRSS3 KLK5	4.13e-05	2	224	2	30755669
Pubmed	Ganglioside GM1 mediates decapacitation effects of SVS2 on murine spermatozoa.	SEMG1 SEMG2	4.13e-05	2	224	2	18753612
Pubmed	Epigenetic signature discriminates lymphatic metastasis in BRAF wild-type thyroid carcinoma: methylation role of GRIK2.	BRAF GRIK2	4.13e-05	2	224	2	37990886
Pubmed	TBL1X: At the crossroads of transcriptional and posttranscriptional regulation.	TBL1X TBL1XR1	4.13e-05	2	224	2	36206873
Pubmed	The immune checkpoint, HVEM may contribute to immune escape in non-small cell lung cancer lacking PD-L1 expression.	TNFRSF14 CD274	4.13e-05	2	224	2	30429008
Pubmed	PD-L1 Expression in colorectal carcinoma and its correlation with clinicopathological parameters, microsatellite instability and BRAF mutation.	BRAF CD274	4.13e-05	2	224	2	34341259
Pubmed	Immunological and Clinico-Molecular Features of Tumor Border Configuration in Colorectal Cancer.	BRAF CD274	4.13e-05	2	224	2	36519916
Pubmed	Bone matrix regulates osteoclast differentiation and annexin A8 gene expression.	ANXA8L1 ANXA8	4.13e-05	2	224	2	21344395
Pubmed	Alternative entry receptors for herpes simplex virus and their roles in disease.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	18005714
Pubmed	PD-L1/B7-H1 regulates the survival but not the function of CD8+ T cells in herpes simplex virus type 1 latently infected trigeminal ganglia.	IFNGR1 CD274	4.13e-05	2	224	2	23656736
Pubmed	γ-Glutamyl cyclotransferase contributes to endometrial carcinoma malignant progression and upregulation of PD-L1 expression during activation of epithelial-mesenchymal transition.	GGCT CD274	4.13e-05	2	224	2	31757677
Pubmed	Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.	ANXA8L1 ANXA8	4.13e-05	2	224	2	16203777
Pubmed	Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans.	SEMG1 SEMG2	4.13e-05	2	224	2	19089943
Pubmed	Molecular cloning and nucleotide sequence of human pancreatic prechymotrypsinogen cDNA.	CTRB2 CTRB1	4.13e-05	2	224	2	2917002
Pubmed	The carbonic anhydrase domain of receptor tyrosine phosphatase beta is a functional ligand for the axonal cell recognition molecule contactin.	PTPRB CNTN1	4.13e-05	2	224	2	7628014
Pubmed	Gene structure of semenogelin I and II. The predominant proteins in human semen are encoded by two homologous genes on chromosome 20.	SEMG1 SEMG2	4.13e-05	2	224	2	1517240
Pubmed	Genomic cloning and partial characterization of human chymotrypsinogen gene.	CTRB2 CTRB1	4.13e-05	2	224	2	8186414
Pubmed	GBP5 promotes liver injury and inflammation by inducing hepatocyte apoptosis.	GBP5 MAP3K14	4.13e-05	2	224	2	34958688
Pubmed	PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.	BRAF CD274	4.13e-05	2	224	2	27198569
Pubmed	Induction of conformational changes at the N-terminus of herpes simplex virus glycoprotein D upon binding to HVEM and nectin-1.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	24314649
Pubmed	Role of Nectin-1 and Herpesvirus Entry Mediator as Cellular Receptors for Herpes Simplex Virus 1 on Primary Murine Dermal Fibroblasts.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	26136572
Pubmed	The mRNA expression and secretion of granzyme B are up-regulated via the histamine H2 receptor in human CD4+ T cells.	HRH2 GZMB	4.13e-05	2	224	2	37470818
Pubmed	Herpesvirus entry mediator is a serotype specific determinant of pathogenesis in ocular herpes.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	23184983
Pubmed	Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: implications for intercellular signaling.	PTPRB CNTN1	4.13e-05	2	224	2	9584610
Pubmed	Annexins: from structure to function.	ANXA8L1 ANXA8	4.13e-05	2	224	2	11917092
Pubmed	The structure of the semenogelin gene locus--nucleotide sequence of the intergenic and the flanking DNA.	SEMG1 SEMG2	4.13e-05	2	224	2	8654389
Pubmed	Seminal vesicle protein SVS2 is required for sperm survival in the uterus.	SEMG1 SEMG2	4.13e-05	2	224	2	24591616
Pubmed	Human Semenogelin 1 Promotes Sperm Survival in the Mouse Female Reproductive Tract.	SEMG1 SEMG2	4.13e-05	2	224	2	32486486
Pubmed	Pathogenesis of neonatal herpes simplex 2 disease in a mouse model is dependent on entry receptor expression and route of inoculation.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	23097453
Pubmed	The cloning of a rapidly evolving seminal-vesicle-transcribed gene encoding the major clot-forming protein of mouse semen.	SEMG1 SEMG2	4.13e-05	2	224	2	8631362
Pubmed	A family with hypothyroidism caused by fatty acid synthase and apolipoprotein B receptor mutations.	APOBR FASN	4.13e-05	2	224	2	30272292
Pubmed	Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.	BRAF CD274	4.13e-05	2	224	2	26110571
Pubmed	Infection of neurons and encephalitis after intracranial inoculation of herpes simplex virus requires the entry receptor nectin-1.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	19805039
Pubmed	Somatic mutations and germline sequence variants in patients with familial colorectal cancer.	EPHB6 CSMD3	4.13e-05	2	224	2	21351276
Pubmed	Annexin A8 controls leukocyte recruitment to activated endothelial cells via cell surface delivery of CD63.	ANXA8L1 ANXA8	4.13e-05	2	224	2	24769558
Pubmed	Chymotrypsin Reduces the Severity of Secretagogue-Induced Pancreatitis in Mice.	CTRB2 CTRB1	4.13e-05	2	224	2	30076839
Pubmed	[Isolation and structure determination of two peptides occurring in human seminal plasma].	SEMG1 SEMG2	4.13e-05	2	224	2	2757795
Pubmed	Sequencing of the complex CTRB1-CTRB2 locus in chronic pancreatitis.	CTRB2 CTRB1	4.13e-05	2	224	2	33036922
Pubmed	Isolation and characterization of the major gel proteins in human semen, semenogelin I and semenogelin II.	SEMG1 SEMG2	4.13e-05	2	224	2	8665951
Pubmed	SEMG1/2 augment energy metabolism of tumor cells.	SEMG1 SEMG2	4.13e-05	2	224	2	33311447
Pubmed	Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.	PKD2 CD274	4.13e-05	2	224	2	22204817
Pubmed	Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry.	SEMG1 SEMG2	4.13e-05	2	224	2	8833737
Pubmed	Evolutionary relationships between laboratory mice and subspecies of Mus musculus based on the restriction fragment length variants of the chymotrypsin gene at the Prt-2 locus.	CTRB2 CTRB1	4.13e-05	2	224	2	2565717
Pubmed	Semen-coagulating protein, SVS2, in mouse seminal plasma controls sperm fertility.	SEMG1 SEMG2	4.13e-05	2	224	2	17123940
Pubmed	Prostasin regulates PD-L1 expression in human lung cancer cells.	PRSS8 CD274	4.13e-05	2	224	2	34240739
Pubmed	Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	21795335
Pubmed	Evolution of the hominoid semenogelin genes, the major proteins of ejaculated semen.	SEMG1 SEMG2	4.13e-05	2	224	2	14629036
Pubmed	Semenogelin I and II, the predominant human seminal plasma proteins, are also expressed in non-genital tissues.	SEMG1 SEMG2	4.13e-05	2	224	2	12200457
Pubmed	Annexins: linking Ca2+ signalling to membrane dynamics.	ANXA8L1 ANXA8	4.13e-05	2	224	2	15928709
Pubmed	Quantification of seminal plasma motility inhibitor/semenogelin in human seminal plasma.	SEMG1 SEMG2	4.13e-05	2	224	2	14581514
Pubmed	SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth.	TBL1X TBL1XR1	4.13e-05	2	224	2	27129164
Pubmed	Entry mechanisms of herpes simplex virus 1 into murine epidermis: involvement of nectin-1 and herpesvirus entry mediator as cellular receptors.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	25320325
Pubmed	Association of nucleotide variations in the apolipoprotein B48 receptor gene (APOB48R) with hypercholesterolemia.	APOBR APOB	4.13e-05	2	224	2	15830122
Pubmed	BRAF-activated WT1 contributes to cancer growth and regulates autophagy and apoptosis in papillary thyroid carcinoma.	BRAF WT1	4.13e-05	2	224	2	35123502
Pubmed	Seminal vesicle secretion 2 acts as a protectant of sperm sterols and prevents ectopic sperm capacitation in mice.	SEMG1 SEMG2	4.13e-05	2	224	2	25395676
Pubmed	Guanylate binding protein 5 triggers NF-κB activation to foster radioresistance, metastatic progression and PD-L1 expression in oral squamous cell carcinoma.	GBP5 CD274	4.13e-05	2	224	2	38185269
Pubmed	FASN Inhibition Decreases MHC-I Degradation and Synergizes with PD-L1 Checkpoint Blockade in Hepatocellular Carcinoma.	FASN CD274	4.13e-05	2	224	2	38486485
Pubmed	Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	15110526
Pubmed	Search for polymorphisms in the genes for herpesvirus entry mediator, nectin-1, and nectin-2 in immune seronegative individuals.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	11756979
Pubmed	Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.	ANXA8L1 ANXA8	4.13e-05	2	224	2	25803307
Pubmed	Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry.	TNFRSF14 NECTIN1	4.13e-05	2	224	2	12915568
Pubmed	Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.	SEMG1 SEMG2	4.13e-05	2	224	2	22177559
Pubmed	BRAFV600E-induced, tumor intrinsic PD-L1 can regulate chemotherapy-induced apoptosis in human colon cancer cells and in tumor xenografts.	BRAF CD274	4.13e-05	2	224	2	31406255
Pubmed	Functional preservation of duplicated pair for RSVS III gene in the REST locus of rat 3q42.	SEMG1 SEMG2	4.13e-05	2	224	2	15582586
Pubmed	Expression of semenogelins I and II and its prognostic significance in human prostate cancer.	SEMG1 SEMG2	4.13e-05	2	224	2	21557275
Pubmed	Multiple bone morphogenetic protein 1-related mammalian metalloproteinases process pro-lysyl oxidase at the correct physiological site and control lysyl oxidase activation in mouse embryo fibroblast cultures.	TLL1 TLL2	4.13e-05	2	224	2	11313359
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	ITIH3 NECTIN1 CNTN1 ATRN APOB MMRN1 MEGF8 SUSD2 MDGA1	4.78e-05	257	224	9	16335952
Pubmed	Prediction of the coding sequences of unidentified human genes. XIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TBRG4 VPS13A NAV3 MYRF WDR37 TLL2	5.37e-05	102	224	6	10231032
Pubmed	A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome.	PRSS3 BPTF NAV2 NBEA APOB EPG5 MEGF8 ARHGAP27	5.94e-05	205	224	8	12040188
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	NECTIN1 ADGRA3 CNTN1 CDON ADGRA2 OPCML MDGA1	9.16e-05	162	224	7	25826454
Cytoband	9q34	FBXW2 TOR1A WDR5 SLC34A3	1.44e-04	54	224	4	9q34
Cytoband	1q21.1	NBPF14 NBPF8 NBPF11 NBPF10	2.47e-04	62	224	4	1q21.1
GeneFamily	WD repeat domain containing	FBXW2 RACK1 WDR35 TBL1X DMXL2 GNB1L NBEA WDR5 WDR37 TBL1XR1 TBL3 TLE3 UTP4 LRBA CFAP44	3.75e-09	262	147	15	362
GeneFamily	Neuroblastoma breakpoint family	NBPF26 NBPF14 NBPF8 NBPF11 NBPF10	9.92e-07	23	147	5	662
GeneFamily	Annexins\|Endogenous ligands	ANXA8L1 ANXA9 ANXA8	1.42e-04	13	147	3	404
GeneFamily	Immunoglobulin like domain containing\|Adhesion G protein-coupled receptors, subfamily A	ADGRA3 ADGRA2	1.96e-04	3	147	2	911
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	CNKSR1 ARHGEF16 AFAP1L2 OSBPL11 OSBPL10 ARAP2 ARHGAP27 FGD6	2.86e-04	206	147	8	682
GeneFamily	Bone morphogenetic proteins\|Astacins	TLL1 TLL2	9.64e-04	6	147	2	894
GeneFamily	Immunoglobulin like domain containing	FCRL3 NECTIN1 CNTN1 CDON ADGRA2 MDGA1 GPA33	1.03e-03	193	147	7	594
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA LRBA	2.28e-03	9	147	2	1230
GeneFamily	Short chain dehydrogenase/reductase superfamily	PECR GFUS FASN HSD11B2	3.42e-03	76	147	4	743
GeneFamily	Oxysterol binding proteins\|Pleckstrin homology domain containing	OSBPL11 OSBPL10	4.11e-03	12	147	2	670
Coexpression	GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP	SMG1 ERAP1 GFUS LCMT2 ATPAF1 TBL1X PTPN21 IFNGR1 TMTC4 GZMB KCTD3 SNRNP200	1.52e-07	199	223	12	M4846
ToppCell	Parenchymal-10x5prime-Stromal-Mesofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EPHB6 ANXA8L1 KLK5 ANXA9 SMOX MYRF CDON CA9 WT1 ANXA8 GRIK2	5.30e-09	197	224	11	88a86286b9c3ea3b076d7464faec42d0392ee7f8
ToppCell	Parenchymal-10x5prime-Stromal-Mesofibroblastic-Mesothelia\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EPHB6 ANXA8L1 KLK5 ANXA9 SMOX MYRF CDON CA9 WT1 ANXA8 GRIK2	5.30e-09	197	224	11	2773d2eb5f232a7e49da116efffcb6bf5eb90810
ToppCell	wk_08-11-Mesenchymal-Mesothelial\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CYP4B1 ANXA8L1 SVIL HRH2 KLK5 MYRF CDON CA9 WT1 DIRAS3	5.95e-08	195	224	10	9016a44b521214546a55a822ebdef5b5312206d2
ToppCell	Bronchial-10x5prime-Stromal-Mesofibroblastic\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EPHB6 ANXA8L1 KLK5 SMOX MYRF CDON CA9 WT1 ANXA8 GRIK2	6.54e-08	197	224	10	438de7f0d35d81d5f5e41dcef7b2c54b6da03df4
ToppCell	Bronchial-10x5prime-Stromal-Mesofibroblastic-Mesothelia\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	EPHB6 ANXA8L1 KLK5 SMOX MYRF CDON CA9 WT1 ANXA8 GRIK2	6.54e-08	197	224	10	26888af95a7cc082a1f1218af35b1f07cb9436ed
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	CYP4B1 ANXA8L1 KLK5 MYRF CDON CA9 WT1 ANXA8 TLL1	4.30e-07	185	224	9	492529121cb9e88bd3c0db6b54af3cd2979572bc
ToppCell	wk_15-18-Mesenchymal-Mesothelial-Late_mesothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CYP4B1 ANXA8L1 KLK5 ANXA9 MYRF CDON CA9 WT1 MDGA1	4.93e-07	188	224	9	38a53f99f1876359983936403aefca93281d10fd
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	CYP4B1 ANXA8L1 KLK5 MYRF CDON CA9 WT1 ANXA8 TLL1	4.93e-07	188	224	9	9655a4c47b644a870017d349b99063e17dbae572
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	ANXA8L1 STXBP2 ANXA9 MYRF CA9 WT1 ANXA8 GRIK2 TLL1	5.38e-07	190	224	9	d82ab67735c1f365d4b0e02b5fa91c64cdc234da
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SLC30A4 TMEM71 ADGRA3 FAM149A LYG2 MAP3K14 ADAMTS10 CD1C	6.65e-07	143	224	8	5a279da1cd8e63db32f7c85a73b493c2121d0a96
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)\|356C / Donor, Lineage, Cell class and subclass (all cells)	PRSS8 CYP4B1 ANXA8L1 ITGA2 NAV2 MYRF PTPN21 SUSD2 MDGA1	6.69e-07	195	224	9	07a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell	356C-Epithelial_cells-Epithelial-I_(AT1)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	PRSS8 CYP4B1 ANXA8L1 ITGA2 NAV2 MYRF PTPN21 SUSD2 MDGA1	6.69e-07	195	224	9	b65511770ed67f7447847e2187555b362988af45
ToppCell	BAL-Control-Myeloid-cDC-cDC-cDC_4\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC30A4 TMEM71 ADGRA3 FAM149A LYG2 MAP3K14 ADAMTS10 CD1C	7.39e-07	145	224	8	997bd540c43725a85ca97e4b79ebe0d336860287
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CSMD2 CSMD3 CNTNAP5 AFAP1L2 ABCC8 CNTN1 SYNE1 OPCML KIF13A	7.93e-07	199	224	9	19a97e27a4758e794ce7246d295e112b47931a48
ToppCell	COVID-19-lung-Mesothelial\|COVID-19 / Disease (COVID-19 only), tissue and cell type	EPHB6 ANXA8L1 ANXA9 MYRF CDON WT1 ANXA8 ODAD2	1.87e-06	164	224	8	83303e2ba52008391b8dc3fae8225ab5bcb20063
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMCO4 ANXA9 MYRF WT1 NFE2L3 TRIM69 LSS CCDC171	2.14e-06	167	224	8	1adb566f98af0109c8cc6e36033b89651e2c75e7
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	TMCO4 ANXA9 MYRF WT1 NFE2L3 TRIM69 LSS CCDC171	2.14e-06	167	224	8	743df5908c1ceb43b34b240d9f9649f30f4142fa
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(RGS5+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPATA31E1 ANXA8L1 TNRC6A KLK5 MYRF CDON WT1 TLL1	3.03e-06	175	224	8	f5451c29c487b998778e50349b3d774d5e20fd28
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 ANXA9 MYRF CDON CA9 WT1	3.58e-06	179	224	8	056df2aaff750e0e283e7da78fcc3c90c366aac0
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 ANXA9 MYRF CDON CA9 WT1	3.58e-06	179	224	8	f5f3945ef3b9efc5921a71fd51deeb2c80f0ce11
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-BEST4+_epithelial\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS3 NBPF26 APOBR HSD11B2 SI NBPF10 GPA33 CDH17	3.73e-06	180	224	8	7c7c4d64ff99d0710a7d19d8bc29fc9217394db1
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 MYRF CDON CA9 WT1 IRX6	3.89e-06	181	224	8	7679a5980011d6dfb1aaca7abf678c29b6f819bb
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 MYRF CDON CA9 WT1 IRX6	3.89e-06	181	224	8	3dcb74b28f93be35ddf4de1937f7e30b25e11927
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 NAV3 CNTN1 EFCAB6 FAT3 APOB ODAD2 XIRP2	4.39e-06	184	224	8	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	wk_20-22-Mesenchymal-Mesothelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ANXA8L1 KLK5 ANXA9 MYRF CDON CA9 WT1 MDGA1	4.39e-06	184	224	8	804f8a41cd6b1361448872bf352bf0a38a0fac66
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 NAV3 CNTN1 EFCAB6 FAT3 APOB ODAD2 XIRP2	4.39e-06	184	224	8	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ANXA8L1 KLK5 ANXA9 MYRF CDON CA9 WT1 MDGA1	4.39e-06	184	224	8	60dd055c2e2e92b838ac649c12e8cccd9c3b1b71
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CSMD3 NAV3 CNTN1 EFCAB6 FAT3 APOB ODAD2 XIRP2	4.39e-06	184	224	8	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EPHB6 KLK5 SMOX GMPPA MYRF CDON CA9 WT1	5.14e-06	188	224	8	e82104f71bcdab7392fdb076dc3560255964fd9e
ToppCell	AT1-AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	PRSS8 CYP4B1 ANXA8L1 HEG1 MYRF ANXA8 PTPN21 SUSD2	5.14e-06	188	224	8	be710bc957118cf426dd71c2d57e6f1b41c9a467
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CYP4B1 ITGA2 PTPRB ARAP2 FAM117B KIAA1671 MMRN1 ARHGAP27	5.78e-06	191	224	8	44c596984c6196f6014e0e405dbe5560841e54ff
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 ANXA9 MYRF CDON CA9 WT1	5.78e-06	191	224	8	5343a527de6b0f852f45020a91f5b4869e78f13a
ToppCell	wk_15-18-Mesenchymal-Mesothelial\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CYP4B1 ANXA8L1 KLK5 ANXA9 MYRF CDON CA9 WT1	5.78e-06	191	224	8	b5374674312ff5803a1d369f5533027532344679
ToppCell	5'-Adult-LymphNode-Epithelial-goblet-BEST2+_Goblet_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF274 ERAP1 CLCA1 HEMK1 BCL2L13 NBEA TRIM69 CASD1	5.78e-06	191	224	8	e5c41c3054ead03597c136eaccaf9822e6bb9d1a
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 ANXA9 MYRF CDON CA9 WT1	5.78e-06	191	224	8	a25a5f9a380031fdaf57677a079f97a90f0550c0
ToppCell	5'-Adult-LymphNode-Epithelial-goblet\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZNF274 ERAP1 CLCA1 HEMK1 BCL2L13 NBEA TRIM69 CASD1	5.78e-06	191	224	8	7e24175c7fabe5ea0b22b73173da4c3a666e5eb8
ToppCell	E16.5-samps-Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CYP4B1 ITGA2 PTPRB ARAP2 FAM117B KIAA1671 MMRN1 ARHGAP27	5.78e-06	191	224	8	e7521d4d24f016d4e531cd492a7a69604f0c9e6f
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	SVIL TNRC6A OSBPL10 ZSWIM6 CUBN ANKRD17 LRBA IMMP2L	6.00e-06	192	224	8	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	nucseq\|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ANKUB1 BRAF CD163L1 NBPF14 ZSWIM6 ANKRD17 LRBA IMMP2L	6.24e-06	193	224	8	779276e775cb2492e8dd36436295a536084a6415
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-J_(Lipofibroblast)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	ANXA8L1 KLK5 MYRF CDON CA9 WT1 ANXA8 NFE2L3	6.48e-06	194	224	8	784b15119c91ace33d34bfb3d68c182566a3e9a8
ToppCell	AT1_cells\|World / lung cells shred on cell class, cell subclass, sample id	PRSS8 CYP4B1 ANXA8L1 HEG1 MYRF ANXA8 PTPN21 SUSD2	6.73e-06	195	224	8	792d6a49b0a875a00569071183d195287a9925c5
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 ANXA9 MYRF CA9 WT1 DIRAS3	6.98e-06	196	224	8	ee89f6884aea11aefeaabe043db7f80145dcdf7f
ToppCell	(7)_Epithelial-I_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	PRSS8 CYP4B1 ANXA8L1 MYRF ANXA8 PTPN21 SUSD2 MDGA1	6.98e-06	196	224	8	150554fa06868d29b0608189862eef6505ba757f
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 ANXA9 MYRF CA9 WT1 DIRAS3	6.98e-06	196	224	8	e75c36cb042342d69a593fb1ce62fab033889871
ToppCell	mild-low-quality_cells\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 NEK10 VPS13A ARAP2 SYNE1 LYG2 ADAMTS10 LRBA	7.25e-06	197	224	8	e4331969bd911d1ebb5453f40a7057297b5389b4
ToppCell	Biopsy_Other_PF-Mesenchymal-Mesothelial_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	EPHB6 ANXA8L1 KLK5 ANXA9 MYRF CA9 WT1 ANXA8	7.52e-06	198	224	8	86736f01e61bf4961f060b24ee1f1f48340737dd
ToppCell	Somatosensory_Cortex_(S1)-Neuronal\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CSMD3 CNTNAP5 CNTN1 SYNE1 NBEA GRIK2 IDS OPCML	7.52e-06	198	224	8	c01091ef18e096d792ea2a7a715764a5b215355f
ToppCell	primary_auditory_cortex_(A1C)-Neuronal\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CSMD3 CNTNAP5 CNTN1 SYNE1 NBEA GRIK2 IDS OPCML	7.52e-06	198	224	8	6d18b45eda4014759e6dd282d78ffd28df8a6044
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS3 PRSS8 SI APOB CUBN SUSD2 GPA33 CDH17	7.52e-06	198	224	8	8fac96132663f54566136ef54b53684d31dfde32
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-mature_enterocytic-Enterocyte\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS3 PRSS8 SI APOB CUBN SUSD2 GPA33 CDH17	7.52e-06	198	224	8	c48b3f026b16d48b8eca9f74dc1e3f3f39a89322
ToppCell	3'-Child09-12-SmallIntestine-Epithelial\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS3 PRSS8 HSD11B2 SI APOB CUBN GPA33 CDH17	7.80e-06	199	224	8	043c65bdf54a1bf0e483fea9ffc042ff5b271764
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CSMD2 CSMD3 CNTNAP5 AFAP1L2 ABCC8 CNTN1 SYNE1 OPCML	7.80e-06	199	224	8	e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SMG1 BPTF BRAF VPS13A ARAP2 SYNE1 LRBA SNRNP200	7.80e-06	199	224	8	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	CNKSR1 PRSS8 CYP4B1 ANXA8L1 NAV2 MYRF PTPN21 SUSD2	7.80e-06	199	224	8	aca81a879ef9c196bd1885eff4c63ffe6c9682b7
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CSMD2 CSMD3 CNTNAP5 AFAP1L2 ABCC8 CNTN1 SYNE1 OPCML	7.80e-06	199	224	8	333056c2abe9724efeab542c0365fcfe4eff8f18
ToppCell	3'-Child04-06-SmallIntestine-Epithelial\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS3 PRSS8 HSD11B2 SI APOB CUBN GPA33 CDH17	7.80e-06	199	224	8	ab71b312635a2b2c98d71b60a299f44bc80a3587
ToppCell	Biopsy_IPF-Mesenchymal-Mesothelial_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	EPHB6 ANXA8L1 KLK5 SMOX MYRF CA9 WT1 ANXA8	8.09e-06	200	224	8	553386523fd8f8f36617a0d81032224b7ddce442
ToppCell	proximal-Epithelial-Alveolar_Epithelial_Type_1\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PRSS8 CYP4B1 ANXA8L1 HEG1 KLK5 MYRF PTPN21 SUSD2	8.09e-06	200	224	8	c1345893e6947ccf9b41282d0e4428dbfb8bcc27
ToppCell	proximal-Epithelial-Alveolar_Epithelial_Type_1-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PRSS8 CYP4B1 ANXA8L1 HEG1 KLK5 MYRF PTPN21 SUSD2	8.09e-06	200	224	8	b652bc73adfdeccbdcd74497ab6e2085e5c95e88
ToppCell	COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated\|COVID-19_Mild / Disease, condition lineage and cell class	FCRL3 GBP5 ARAP2 SYNE1 KIAA1671 GZMB NBPF10 IL2RB	8.09e-06	200	224	8	2281debd86e5d92e8fe0397aec9ef670800f7471
ToppCell	proximal-3-Epithelial-Alveolar_Epithelial_Type_1\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	PRSS8 CYP4B1 ANXA8L1 HEG1 KLK5 MYRF PTPN21 SUSD2	8.09e-06	200	224	8	51f8fc43c069f2c4e75588d28ae6deb5d7ed2c86
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ITGA2 CD163L1 KLK5 APOB MMRN1	1.18e-05	59	224	5	ebc80c32b56e97c3ab3ac5ae00f06f7f2bcc3d39
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Camk2d_(CA1_Principal_cells)-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ITGA2 CD163L1 KLK5 APOB MMRN1	1.18e-05	59	224	5	719728ed089762ae79cbfbe56c4171d70361a772
ToppCell	Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Dcn-Excitatory_Neuron.Slc17a7.Dcn-Camk2d_(CA1_Principal_cells)\|Hippocampus / BrainAtlas - Mouse McCarroll V32	ITGA2 CD163L1 KLK5 APOB MMRN1	1.18e-05	59	224	5	55954d610f5a813ef15ab5e898c5ad309fc9e319
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	CSMD2 SPTBN5 AFAP1L2 CNTN1 GRIK2 OPCML KIF13A	1.37e-05	155	224	7	77fdae85d36efb776db977eb424b32487ef222e4
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NEK10 PTPRB VWA5B1 FAT3 SLC34A3 MMRN1 CTRL	1.37e-05	155	224	7	8fdda4e3657ac56188ae88ed3caf145f4d9d1567
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PKD1L1 ITIH3 MYRF SLC34A3 NLRP2 NFE2L3	1.44e-05	104	224	6	30b2f6f6612ea45c92f0d466e301d85291a2ee70
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PKD1L1 ITIH3 MYRF SLC34A3 NLRP2 NFE2L3	1.44e-05	104	224	6	a0e03cc97d453050c6b7e6e290ef0babc7bc1276
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	PKD1L1 ITIH3 MYRF SLC34A3 NLRP2 NFE2L3	1.44e-05	104	224	6	3cc15f0abdf1f4304af9152911a1f3aab3bc0925
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TNFRSF14 KLHL30 ANXA8 CUBN XIRP2 BMP15	1.60e-05	106	224	6	7079111add27d7b3411dfe739280d62dc256a174
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.Dapl1_(Dapl1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	TNFRSF14 KLHL30 ANXA8 CUBN XIRP2 BMP15	1.60e-05	106	224	6	a6334b67be05f78145b57271b7959471b80bd67f
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	CSMD2 CSMD3 CNTNAP5 NAV3 FAT3 OPCML XIRP2	1.62e-05	159	224	7	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 CNTN1 SYNE1 WT1 NBEA GRIK2 ADGRA2	1.62e-05	159	224	7	5ca96db4281abb5f646150ccf36adc66ab201c78
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 ABCC8 CNTN1 WT1 GRIK2 ADGRA2 OPCML	1.76e-05	161	224	7	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	3'-Adult-SmallIntestine-Epithelial-mature_enterocytic-Paneth\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZBED10P MYRF FAM149A UBE2C APOB DIRAS3 ZNF45	1.83e-05	162	224	7	768a566e76923323c1f197f60bab472a8784490b
ToppCell	facs-Kidney-nan-24m\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRSS3 CYP4B1 RACK1 CA9 UBE2C CTRB1 CTRL	1.83e-05	162	224	7	f223ea00cf7fbc25e6d5a946ee1ff05f7d4abb06
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 CNTN1 SYNE1 WT1 SI GRIK2 ADGRA2	1.98e-05	164	224	7	f6a961fa2002da7d9679f32af99e1314c0593ef9
ToppCell	droplet-Limb_Muscle-nan-3m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TECPR2 SYNJ2 MAP3K14 CRYBA4 TMTC4 FGD6 NEURL4	2.14e-05	166	224	7	35db3022c33d6f8bb6587d9eec89a7cccb70271a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 CNTN1 SYNE1 WT1 NBEA GRIK2 ADGRA2	2.50e-05	170	224	7	876b84740e15399bfff2b9c7f0b80fd759bbdb3f
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 CNTN1 SYNE1 WT1 NBEA GRIK2 ADGRA2	2.50e-05	170	224	7	1f8738acf439d893880db7e1fdc9b3615ca00c39
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 CNTN1 SYNE1 WT1 GRIK2 ADGRA2 OPCML	2.69e-05	172	224	7	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AFAP1L2 CNTN1 SYNE1 WT1 GRIK2 ADGRA2 OPCML	2.69e-05	172	224	7	553701349444eb366df3c11f54bb093434f153c6
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ANXA8L1 KLK5 ANXA9 MYRF WT1 ANXA8 TLL1	2.79e-05	173	224	7	3d7c281a1a9f183a5a861d1a9c7b50d216535893
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ANXA8L1 KLK5 ANXA9 MYRF WT1 ANXA8 TLL1	2.79e-05	173	224	7	3aa90578371039f81b7c6fa873ec70f8f2bc7dfa
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Epithelial-epithelial_progenitor_cell-Distal_progenitor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	PRSS8 APOBR NECTIN1 VWA5B1 ARHGAP27 GPA33 CDH17	2.79e-05	173	224	7	81c36b9fe02c59099f080b2db02f4eaf2783911f
ToppCell	droplet-Heart-HEART-1m-Endothelial-leukocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITIH3 TMCO4 AFAP1L2 BCL2L13 PDSS2 MMRN1 TLL1	2.79e-05	173	224	7	9dc7746a84f0e268a7c061e1bbcd5e31903034dc
ToppCell	COVID-19-kidney-REN+Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CTRB2 AFAP1L2 HRH2 CNTN1 TBL1X NBEA ADGRA2	2.90e-05	174	224	7	8393f0b43c767839c1630bcb952d62b42efc788d
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 PRSS8 CYP4B1 CDON ANXA8 WFDC3 ACCSL	3.72e-05	181	224	7	a5e770b5b5d57cbac18560828e89f7c96b687743
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 PRSS8 CYP4B1 CDON ANXA8 WFDC3 ACCSL	3.72e-05	181	224	7	504b1af1951a7a20ef5db69d84c20630ec64095b
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 PRSS8 CYP4B1 CDON ANXA8 WFDC3 ACCSL	3.72e-05	181	224	7	a55ec36d2393f7a376feb42b22aee75dfdf4c383
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	CYP4B1 ITGA2 TMEM71 CLCA1 PTPRB ARAP2 MMRN1	3.86e-05	182	224	7	7af3b2029b7f55b923d5a4b764d4292f4ea48599
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	CYP4B1 ANXA8L1 NAV2 MYRF ANXA8 PTPN21 SUSD2	3.86e-05	182	224	7	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	E18.5-samps-Endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	CYP4B1 ITGA2 TMEM71 CLCA1 PTPRB ARAP2 MMRN1	3.86e-05	182	224	7	e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1
ToppCell	E16.5-samps-Endothelial-Immature_fetal_endothelial-Intermediate_Endothelial\|E16.5-samps / Age Group, Lineage, Cell class and subclass	CYP4B1 ITGA2 CLCA1 PTPRB ARAP2 KIAA1671 ARHGAP27	3.86e-05	182	224	7	fec1caf867b1dc87b24504d895ee1a27df78062e
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 MYRF CDON CA9 WT1	3.99e-05	183	224	7	9d5a363fbe6f0a1668c9d584df65ee1c283349c7
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-mesothelial_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CYP4B1 ANXA8L1 KLK5 MYRF CDON CA9 WT1	3.99e-05	183	224	7	c5caac6ed6c8d67f5c336281d9fd903976509445
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ANXA8L1 KLK5 ANXA9 MYRF CA9 LAMB4 WT1	3.99e-05	183	224	7	03649492c37f9b274a1caf3e2132ce2915cf1df5
ToppCell	(7)_Epithelial-H_(AT1)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	PRSS8 CYP4B1 ANXA8L1 ITGA2 ARHGEF16 NECTIN1 ANXA8	4.13e-05	184	224	7	1f76b37c265b519171b767a52d48f31f0cdc4a3c
ToppCell	droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CNKSR1 PRSS8 ARHGEF16 NAV2 MYRF FAT3 NFE2L3	4.13e-05	184	224	7	6388c47b7f1d8203e3069eba0e74107256dcae51
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PECR BRAF HRH2 GNB1L MUC12 EPG5 CASD1	4.13e-05	184	224	7	2c2125b8030af83f7a6d59a7102d4de8e0ac1988
Drug	pentaammineaquocobalt(III) tetrafluoroborate	PRSS3 CTRB2 ITGA2 CTRB1	3.01e-07	7	222	4	CID000412963
Drug	diphenylcarbamyl chloride	PRSS3 CTRB2 CA9 CTRB1 CTRL	3.37e-07	16	222	5	CID000065741
Drug	3,5-bis-trifluoromethylphenylboronic acid	PRSS3 CTRB2 LRBA CTRB1	5.97e-07	8	222	4	CID000156265
Drug	3-Cl	CTRB2 ITGA2 IDS CTRB1 CTRL	1.51e-06	21	222	5	CID000012313
Drug	Benzoyl-dl-leucine	CTRB2 CTRB1 CTRL	3.63e-06	4	222	3	CID000294887
Drug	G2505_sigma	CTRB2 CTRB1 CTRL	3.63e-06	4	222	3	CID000111098
Drug	CP094	PRSS3 GCKR TRPM8 KLK5 HSD11B2 SEMG1 SEMG2 CUBN CD274 CTRL	5.31e-06	165	222	10	CID000086322
Drug	AC1L8TCY	PRSS3 CTRB2 HRH2 SLC27A5 CTRB1	5.71e-06	27	222	5	CID000407798
Drug	phenyl 4-guanidinobenzoate	PRSS3 CTRB2 CNTN1 CTRB1	5.87e-06	13	222	4	CID003015798
Drug	Lb I	PRSS3 CTRB2 LSS LRBA CTRB1	6.90e-06	28	222	5	CID000161844
Drug	APMSF	PRSS3 CTRB2 APOB LCT CTRB1 CTRL	7.00e-06	48	222	6	CID000001719
Drug	BTPNA	PRSS3 CTRB2 CTRB1 CTRL	1.10e-05	15	222	4	CID000188992
Drug	ONO-3307	PRSS3 CTRB2 CNTN1 CTRB1	1.10e-05	15	222	4	CID000127139
Drug	N-benzoyl-L-tyrosine	PRSS3 CTRB2 CTRB1 CTRL	1.10e-05	15	222	4	CID000151021
Drug	N-benzoyltyrosine butylamide	PRSS3 CTRB2 CTRB1	1.79e-05	6	222	3	CID000125261
Drug	N-benzoyl-L-tyrosine thiobenzyl ester	PRSS3 CTRB2 CTRB1	1.79e-05	6	222	3	CID000191444
Drug	N,N-dimethylglycylbenzocaine	PRSS3 CTRB2 CTRB1	1.79e-05	6	222	3	CID000188251
Drug	2-azidoatrazine	PRSS3 CTRB2 CTRB1	1.79e-05	6	222	3	CID003032432
Drug	cyanogen-bromide	PRSS3 CTRB2 ITGA2 SYNE1 CTRB1	1.86e-05	34	222	5	CID000010476
Drug	Dioxybenzone [131-53-3]; Up 200; 16.4uM; PC3; HT_HG-U133A	PAPOLB ITGA2 ARHGEF16 HEG1 HEMK1 DTX3 WT1 APOB LSS SNRNP200	2.84e-05	200	222	10	4638_UP
Drug	H-boronorleucine	CA9 SYNE1 LRBA CTRL	3.04e-05	19	222	4	CID000469539
Drug	Cbz-phe-arg-chn2	PRSS3 CTRB2 CTRB1	3.11e-05	7	222	3	CID005492392
Drug	Z-Phe-OH	CTRB2 CTRB1 CTRL	3.11e-05	7	222	3	CID000070878
Drug	AC1MCHYW	PRSS3 CTRB2 CTRB1	4.94e-05	8	222	3	CID002770087
Drug	AcPheOEt	CTRB2 CTRB1 CTRL	4.94e-05	8	222	3	CID000094229
Drug	ATNE	CTRB2 CTRB1 CTRL	4.94e-05	8	222	3	CID000130551
Drug	Bio-Phe-CH2Cl	PRSS3 CTRB2 CTRB1	4.94e-05	8	222	3	CID000083924
Drug	Bio-Arg-CH2Cl	PRSS3 CTRB2 CTRB1	4.94e-05	8	222	3	CID000083923
Drug	Z-Phe-OMC	CTRB2 CTRB1 CTRL	4.94e-05	8	222	3	CID000127395
Drug	T.E.E	CTRB2 CTRB1 CTRL	4.94e-05	8	222	3	CID000061327
Drug	BOC-Ala-OMC	CTRB2 CTRB1 CTRL	4.94e-05	8	222	3	CID000132159
Drug	boronic acids	CTRB2 ITGA2 CTRB1 CTRL	5.61e-05	22	222	4	CID000139619
Drug	pyrenebutyl methylphosphonofluoridate	CTRB2 FASN CTRB1	7.36e-05	9	222	3	CID000125653
Drug	FK-401	PRSS3 CTRB2 CTRB1	7.36e-05	9	222	3	CID000135041
Drug	Suphepa	CTRB2 CTRB1 CTRL	7.36e-05	9	222	3	CID000102818
Drug	tlmE	PRSS3 CTRB2 CTRB1	7.36e-05	9	222	3	CID000188322
Drug	AC1NRA23	PRSS3 PRSS8 CTRB2 CUBN CTRB1 CTRL	7.93e-05	73	222	6	CID005287657
Drug	BOCPheONP	CTRB2 CTRB1	9.46e-05	2	222	2	CID000111308
Drug	MPM-06	CTRB2 CTRB1	9.46e-05	2	222	2	CID000161546
Drug	NSC-374899	CTRB2 CTRB1	9.46e-05	2	222	2	CID000435726
Drug	methylbenzenebutanoate	CTRB2 CTRB1	9.46e-05	2	222	2	CID000281254
Drug	Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu	CTRB2 CTRB1	9.46e-05	2	222	2	CID004418081
Drug	c189	CTRB2 CTRB1	9.46e-05	2	222	2	CID000248048
Drug	dansyl-D-arginine methyl ester	CTRB2 CTRB1	9.46e-05	2	222	2	CID000191369
Drug	methyl 6-phenylhexanoate	CTRB2 CTRB1	9.46e-05	2	222	2	CID011820300
Drug	5-aminotetrazole	CTRB2 CTRB1	9.46e-05	2	222	2	CID000020467
Drug	2-bromoisobutyric acid	CTRB2 CTRB1	9.46e-05	2	222	2	CID000074924
Drug	p-toluamidine	CTRB2 CTRB1	9.46e-05	2	222	2	CID000122753
Drug	N-acetyl-alpha-azaphenylalanine phenyl ester	CTRB2 CTRB1	9.46e-05	2	222	2	CID000191275
Drug	topsentin	ITGA2 SYNE1	9.46e-05	2	222	2	CID000072457
Drug	isobutyl sulfide	CTRB2 CTRB1	9.46e-05	2	222	2	CID000011607
Drug	RD4-6205	PRSS3 CTRB2 CTRB1	1.04e-04	10	222	3	CID003002865
Drug	D-pyroglutamate	PRSS3 CTRB2 GGCT SEMG1 SEMG2 CTRB1 BMP15	1.16e-04	112	222	7	CID000000499
Drug	Pentylenetetrazole [54-95-5]; Down 200; 29uM; HL60; HG-U133A	TBRG4 SIGMAR1 GFUS LCMT2 STXBP2 PRRC2A SLC25A24 TBL3 TMEM131	1.27e-04	194	222	9	1408_DN
Drug	Mefexamide hydrochloride [3413-64-7]; Up 200; 12.6uM; PC3; HT_HG-U133A	KLK5 SYNE1 DTX3 PTPN21 TMEM38B OPCML IFNGR1 TLE3 TMEM63A	1.32e-04	195	222	9	2121_UP
Drug	Carteolol hydrochloride [51781-21-6]; Down 200; 12.2uM; PC3; HT_HG-U133A	ARHGEF16 ZBED4 WT1 GRIK2 PTPN21 IDS ZNF45 TLE3 TMEM63A	1.42e-04	197	222	9	4096_DN
Drug	26-nor-25-doxylcholestanol	PRSS3 CTRB2 CTRB1	1.42e-04	11	222	3	CID000125890
Drug	Z-Gly-Gly-Leu	CTRB2 CTRB1 CTRL	1.42e-04	11	222	3	CID000297862
Drug	Es 6864	PRSS3 CTRB2 CTRB1	1.42e-04	11	222	3	CID003082786
Drug	tetrazol-5-imine	CTRB2 CPA5 CTRB1	1.42e-04	11	222	3	CID000407223
Drug	Boroval	CTRB2 CTRB1 CTRL	1.42e-04	11	222	3	CID005487930
Drug	Solasodine [126-17-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A	EPHB6 ERAP1 PTPRB NECTIN1 HEMK1 LAMB4 MEGF8 PRDM16 ZNF646	1.48e-04	198	222	9	6025_UP
Drug	Chlorzoxazone [95-25-0]; Down 200; 23.6uM; MCF7; HT_HG-U133A	SIGMAR1 SPART NHLRC2 SYNJ2 VPS13A TBL1X ATRN MAP3K14 CASD1	1.48e-04	198	222	9	7456_DN
Drug	(S)-(-)-Cycloserine [339-72-0]; Up 200; 39.2uM; MCF7; HT_HG-U133A	SPART PTPRB TBCEL SYNE1 ADGRA2 OPCML DIRAS3 PRDM16 BMP15	1.48e-04	198	222	9	4346_UP
Drug	aspirin, USP; Up 200; 100uM; PC3; HT_HG-U133A	TECPR2 CDON DTX3 GRIK2 PTPN21 ADGRA2 MEGF8 TMEM63A ZNF646	1.48e-04	198	222	9	4428_UP
Drug	Z-Lys-OH	PRSS3 GZMB CTRL IL2RB	1.50e-04	28	222	4	CID000075172
Drug	Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A	PTPRB SYNJ2 HEMK1 CA9 DMXL2 PTPN21 OPCML CD1C TMEM63A	1.54e-04	199	222	9	2289_UP
Drug	Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; PC3; HT_HG-U133A	KIAA0753 VPS13A NAV3 OSBPL11 SLC25A17 GNB1L NBEA IDS PITPNM1	1.60e-04	200	222	9	2061_DN
Drug	N-Ac-D-E	HSD11B2 SYNE1 GRIK2 LCT GRM8	1.65e-04	53	222	5	CID000005255
Drug	camostate	PRSS3 PRSS8 CTRB2 KLK5 HSD11B2 CTRB1	2.24e-04	88	222	6	CID000002536
Drug	2-hexulofuranose	PRSS3 GCKR PFKFB1 SEMG1 SEMG2 SI	2.24e-04	88	222	6	CID000000716
Drug	Pd-Ti	PRSS3 CTRB2 CTRB1	2.43e-04	13	222	3	CID006452040
Drug	Lga-afc	CTRB2 CTRB1 CTRL	2.43e-04	13	222	3	CID003081120
Drug	N-acetylbenzotriazole	CTRB2 CTRB1	2.82e-04	3	222	2	CID000087784
Drug	photophor	CTRB2 CTRB1	2.82e-04	3	222	2	CID000014780
Drug	dibutyl iodomethaneboronate	CTRB2 CTRB1	2.82e-04	3	222	2	CID000098591
Drug	zinc;dipicolinate	CTRB2 CTRB1	2.82e-04	3	222	2	CID004309911
Drug	2-oxobut-3-ynoate	CTRB2 CTRB1	2.82e-04	3	222	2	CID000171547
Drug	AFMeq	CTRB2 CTRB1	2.82e-04	3	222	2	CID000194069
Drug	Bz-Cti-otbu	CTRB2 CTRB1	2.82e-04	3	222	2	CID006452691
Drug	n-(2-oxoethyl)benzamide	CTRB2 CTRB1	2.82e-04	3	222	2	CID000188995
Drug	AC1L49DM	CTRB2 CTRB1	2.82e-04	3	222	2	CID000152933
Drug	c140	CTRB2 CTRB1	2.82e-04	3	222	2	CID002783250
Drug	Benzamidomethaneboronic acid	CTRB2 CTRB1	2.82e-04	3	222	2	CID000127677
Drug	phenyl hippurate	CTRB2 CTRB1	2.82e-04	3	222	2	CID000076323
Drug	FK-386	CTRB2 CTRB1	2.82e-04	3	222	2	CID000135044
Drug	FK-375	CTRB2 CTRB1	2.82e-04	3	222	2	CID000135042
Drug	carbostyril-124	CTRB2 CTRB1	2.82e-04	3	222	2	CID000088277
Drug	N-trifluoroacetyl-4-fluorophenylalanine	CTRB2 CTRB1	2.82e-04	3	222	2	CID000328214
Drug	C18 4	CTRB2 CTRB1	2.82e-04	3	222	2	CID000077248
Drug	m-benzenediacetic acid	ITGA2 SYNE1	2.82e-04	3	222	2	CID000029788
Drug	taraxastane	CTRB2 CTRB1	2.82e-04	3	222	2	CID006429404
Drug	Phe-phe-ome	CTRB2 CTRB1	2.82e-04	3	222	2	CID000151728
Drug	phenylethaneboronic acid	CTRB2 CTRB1	2.82e-04	3	222	2	CID000065389
Drug	3-amino-2-pyridone	CTRB2 CTRB1	2.82e-04	3	222	2	CID000322353
Drug	ASA-BMPA	CTRB2 CTRB1	2.82e-04	3	222	2	CID003035649
Drug	aptiganel HCl	SIGMAR1 ITGA2	2.82e-04	3	222	2	CID011954290
Drug	p-nitrophenyl benzoate	CTRB2 CTRB1	2.82e-04	3	222	2	CID000070396
Drug	Z-Phe-OMe	CTRB2 CTRB1	2.82e-04	3	222	2	CID003082435
Drug	3-methylcoumarin	CTRB2 CTRB1	2.82e-04	3	222	2	CID000017130
Disease	Malignant neoplasm of breast	FASN FCRL3 BRAF SYNJ2 OSBPL11 HERC2 SMOX PRRC2A KIF6 SYNE1 DTX3 GNB1L UBE2C WT1 GRIK2 CUBN PALB2 EPG5 SLC8A3 TMTC4 TLE3 TLL1 GZMB LRBA ZNF646	2.87e-07	1074	213	25	C0006142
Disease	level of chymotrypsinogen B2 in blood serum	CTRB2 CTRB1	5.19e-05	2	213	2	OBA_2041192
Disease	trypsin-2 measurement	EPHB6 CTRB2 CTRB1	5.86e-05	11	213	3	EFO_0008305
Disease	bipolar disorder	ITIH3 BRAF SLC25A17 CNTN1 SEMG1 SEMG2 SYNE1 CARMIL1 ZSWIM6 PALB2 SLC8A3 TLE3 TMEM131 IMMP2L	8.57e-05	577	213	14	MONDO_0004985
Disease	chymotrypsinogen B measurement	CTRB2 CTRB1	1.55e-04	3	213	2	EFO_0801477
Disease	glomerulonephritis	OSBPL10 PRRC2A	1.55e-04	3	213	2	MONDO_0002462
Disease	sensory system disease (implicated_via_orthology)	TBL1X TBL1XR1	1.55e-04	3	213	2	DOID:0050155 (implicated_via_orthology)
Disease	cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement	GCKR NHLRC2 BPTF MCUB MYRF DMGDH CARMIL1 APOB NFE2L3	1.92e-04	276	213	9	EFO_0004612, EFO_0020943
Disease	lifestyle measurement, alcohol consumption measurement	CYP8B1 CSMD2 KIF6 GRIK2 LRBA CDH17	1.93e-04	115	213	6	EFO_0007878, EFO_0010724
Disease	coffee consumption, cups of coffee per day measurement	GCKR PDSS2 OPCML	1.94e-04	16	213	3	EFO_0004330, EFO_0006782
Disease	very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio	GCKR NHLRC2 BPTF ANXA9 MCUB MYRF DMGDH APOB NFE2L3	2.84e-04	291	213	9	EFO_0008317, EFO_0020946
Disease	post-traumatic stress disorder symptom measurement	CPA5 SYNE1 NBEA OPCML IMMP2L	3.25e-04	82	213	5	EFO_0008535
Disease	Breast Carcinoma	FASN BRAF SYNJ2 HERC2 SYNE1 DTX3 UBE2C WT1 GRIK2 PALB2 TLE3 GZMB	5.81e-04	538	213	12	C0678222
Disease	cholesteryl esters to total lipids in very large VLDL percentage	GCKR MYRF APOB NFE2L3	5.86e-04	53	213	4	EFO_0022258
Disease	cholesterol to total lipids in very large VLDL percentage	GCKR MYRF APOB NFE2L3	6.29e-04	54	213	4	EFO_0022244
Disease	cholesterol to total lipids in large HDL percentage	GCKR DMGDH APOB NFE2L3	6.75e-04	55	213	4	EFO_0022234
Disease	cholesteryl esters to total lipids in large VLDL percentage	GCKR MYRF APOB NFE2L3	7.23e-04	56	213	4	EFO_0022250
Disease	gondoic acid measurement	GCKR MYRF	7.63e-04	6	213	2	EFO_0007975
Disease	rhegmatogenous retinal detachment	GFUS FAT3	7.63e-04	6	213	2	EFO_0005240
Disease	low density lipoprotein cholesterol measurement, multiple sclerosis	FCRL3 MAP3K14	7.63e-04	6	213	2	EFO_0004611, MONDO_0005301
Disease	triglyceride measurement, high density lipoprotein cholesterol measurement	GCKR BPTF DMGDH KIF6 CARMIL1 APOB WDR5 NFE2L3	8.94e-04	274	213	8	EFO_0004530, EFO_0004612
Disease	triglycerides in small VLDL measurement	GCKR BPTF DMGDH APOB	9.98e-04	61	213	4	EFO_0022145
Disease	triglycerides in small HDL measurement	GCKR BPTF DMGDH APOB	1.06e-03	62	213	4	EFO_0022158
Disease	phospholipids in large VLDL measurement	GCKR ITIH3 BPTF APOB	1.06e-03	62	213	4	EFO_0022169
Disease	Writer's Cramp	TOR1A PRKRA	1.06e-03	7	213	2	C4316810
Disease	Dystonia Disorders	TOR1A PRKRA	1.06e-03	7	213	2	C0393593
Disease	Idiopathic familial dystonia	TOR1A PRKRA	1.06e-03	7	213	2	C0393598
Disease	Adult-Onset Idiopathic Focal Dystonias	TOR1A PRKRA	1.06e-03	7	213	2	C0752198
Disease	Adult-Onset Dystonias	TOR1A PRKRA	1.06e-03	7	213	2	C0752197
Disease	Adult-Onset Idiopathic Torsion Dystonias	TOR1A PRKRA	1.06e-03	7	213	2	C0752199
Disease	Autosomal Dominant Familial Dystonia	TOR1A PRKRA	1.06e-03	7	213	2	C0752200
Disease	Childhood Onset Dystonias	TOR1A PRKRA	1.06e-03	7	213	2	C0752202
Disease	Autosomal Recessive Familial Dystonia	TOR1A PRKRA	1.06e-03	7	213	2	C0752201
Disease	Dystonia, Primary	TOR1A PRKRA	1.06e-03	7	213	2	C0752203
Disease	Dystonias, Sporadic	TOR1A PRKRA	1.06e-03	7	213	2	C0752206
Disease	Dystonia, Secondary	TOR1A PRKRA	1.06e-03	7	213	2	C0752205
Disease	Pseudodystonia	TOR1A PRKRA	1.06e-03	7	213	2	C0752208
Disease	Familial Dystonia	TOR1A PRKRA	1.06e-03	7	213	2	C0752207
Disease	Focal Dystonia	TOR1A PRKRA	1.06e-03	7	213	2	C0743332
Disease	triglycerides to total lipids in medium VLDL percentage	GCKR MYRF DMGDH NFE2L3	1.13e-03	63	213	4	EFO_0022335
Disease	Myeloid Leukemia, Chronic	BRAF CA9 WT1	1.18e-03	29	213	3	C0023473
Disease	Headache	STXBP2 TRPM8 NFE2L3 PRDM16	1.20e-03	64	213	4	HP_0002315
Disease	triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement	GCKR NHLRC2 MYRF DMGDH APOB NFE2L3 LRBA	1.30e-03	225	213	7	EFO_0008317, EFO_0020947
Disease	phospholipids:total lipids ratio	GCKR BPTF ANXA9 MYRF DMGDH APOB NFE2L3	1.36e-03	227	213	7	EFO_0020946
Disease	level of Phosphatidylinositol (16:0_20:4) in blood serum	GCKR MYRF	1.41e-03	8	213	2	OBA_2045154
Disease	Ovarian Mucinous Adenocarcinoma	EPHB6 NEK10 MAP3K14	1.44e-03	31	213	3	C1335167
Disease	colorectal cancer	TBRG4 ERAP1 NHLRC2 SYNJ2 HERC2 MYRF SLC27A5 PIWIL4 GRIK2 CUBN LRBA CFAP44	1.56e-03	604	213	12	MONDO_0005575
Disease	triglycerides to total lipids in very small VLDL percentage	GCKR MYRF DMGDH APOB	1.58e-03	69	213	4	EFO_0022341
Disease	Acute Confusional Migraine	TRPM8 PRDM16	1.81e-03	9	213	2	C0521664
Disease	Status Migrainosus	TRPM8 PRDM16	1.81e-03	9	213	2	C0338489
Disease	Abdominal Migraine	TRPM8 PRDM16	1.81e-03	9	213	2	C0270858
Disease	Sick Headaches	TRPM8 PRDM16	1.81e-03	9	213	2	C0700438
Disease	Cervical Migraine Syndrome	TRPM8 PRDM16	1.81e-03	9	213	2	C0007852
Disease	Hemicrania migraine	TRPM8 PRDM16	1.81e-03	9	213	2	C0018984
Disease	very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	GCKR NHLRC2 MYRF DMGDH CARMIL1 APOB NFE2L3	1.83e-03	239	213	7	EFO_0008317, EFO_0020945
Disease	plasma betaine measurement	DCDC1 DMGDH LY75	1.88e-03	34	213	3	EFO_0007787
Disease	cholesterol:total lipids ratio, intermediate density lipoprotein measurement	GCKR MCUB DMGDH APOB NFE2L3	1.89e-03	121	213	5	EFO_0008595, EFO_0020943
Disease	cholesteryl esters:total lipids ratio, high density lipoprotein cholesterol measurement	GCKR BPTF MCUB DMGDH CARMIL1 APOB NFE2L3	2.01e-03	243	213	7	EFO_0004612, EFO_0020944
Disease	free cholesterol to total lipids in large LDL percentage	GCKR MYRF DMGDH APOB	2.05e-03	74	213	4	EFO_0022280
Disease	coronary aneurysm	CSMD2 NAV2 MDGA1	2.05e-03	35	213	3	EFO_1000881
Disease	creatinine measurement, chronic kidney disease	GCKR ANXA9 WDR37	2.05e-03	35	213	3	EFO_0003884, EFO_0004518
Disease	free cholesterol to total lipids in small VLDL percentage	GCKR DMGDH APOB NFE2L3	2.15e-03	75	213	4	EFO_0022287
Disease	non-high density lipoprotein cholesterol measurement	CNKSR1 GCKR NHLRC2 BPTF CD163L1 ANXA9 MYRF SLC25A17 NRDC CARMIL1 APOB GRIK2 NFE2L3	2.15e-03	713	213	13	EFO_0005689
Disease	Asthma, Occupational	HERC2 CDH17	2.25e-03	10	213	2	C0264423
Disease	1,7-dimethylurate measurement	ITGA2 GRIK2	2.25e-03	10	213	2	EFO_0021512
Disease	level of Triacylglycerol (51:3) in blood serum	GCKR APOB	2.25e-03	10	213	2	OBA_2045163
Disease	level of Phosphatidylcholine (18:0_22:5) in blood serum	GCKR MYRF	2.25e-03	10	213	2	OBA_2045096
Disease	attention deficit hyperactivity disorder, parental emotion expression measurmement	KIF6 PIWIL4	2.25e-03	10	213	2	EFO_0003888, EFO_0008342
Disease	theophylline measurement	ITGA2 NAV2	2.25e-03	10	213	2	EFO_0021180
Disease	Bipolar Disorder	ITIH3 RACK1 SYNE1 GNB1L GRIK2 PALB2 TLL2 MDGA1 IL2RB CDH17	2.59e-03	477	213	10	C0005586
Disease	level of Diacylglycerol (18:1_18:1) in blood serum	GCKR APOB	2.73e-03	11	213	2	OBA_2045170
Disease	serum gamma-glutamyl transferase measurement	GCKR CSMD3 BPTF SYNJ2 SVIL NAV2 ANXA9 PRRC2A ARAP2 TBL1X DMGDH ATRN NFE2L3 LRBA CCDC171	2.77e-03	914	213	15	EFO_0004532
Disease	degree of unsaturation measurement	GCKR MYRF APOB	2.80e-03	39	213	3	EFO_0022261
Disease	alcohol drinking	GCKR TRPM8 ARAP2 FAT3	2.85e-03	81	213	4	EFO_0004329
Disease	Autistic Disorder	CSMD3 NBEA GRIK2 GRM8 TBL1XR1 GZMB IMMP2L	2.99e-03	261	213	7	C0004352
Disease	cholesteryl ester 18:3 measurement	NAV2 MYRF APOB	3.01e-03	40	213	3	EFO_0010346
Disease	Neoplasm of uncertain or unknown behavior of breast	BRAF HERC2 PALB2	3.23e-03	41	213	3	C0496956
Disease	Breast adenocarcinoma	BRAF HERC2 PALB2	3.23e-03	41	213	3	C0858252
Disease	lifestyle measurement, anxiety disorder measurement	CYP8B1 CSMD2 GRIK2 OPCML LRBA	3.23e-03	137	213	5	EFO_0007795, EFO_0010724
Disease	dodecanedioate measurement	IFNGR1 MDGA1	3.26e-03	12	213	2	EFO_0021054
Disease	asthma	NEK10 TNFRSF14 ERMP1 CSMD3 TRPM8 MYRF SEMG2 DMXL2 MAP3K14 TBL1XR1 ARHGAP27 IL2RB PRDM16	3.35e-03	751	213	13	MONDO_0004979
Disease	low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio	GCKR MCUB DMGDH CARMIL1 APOB NFE2L3	3.41e-03	200	213	6	EFO_0004611, EFO_0020945
Disease	serum metabolite measurement	ERAP1 CYP4B1 PKD1L1 ERMP1 GCKR GFUS TRPM8 MYRF DMGDH LAMB4 PDSS2 LINC00469 APOB GRIK2 MDGA1	3.77e-03	945	213	15	EFO_0005653
Disease	level of Sphingomyelin (d34:2) in blood serum	MYRF ANKRD17	3.84e-03	13	213	2	OBA_2045174
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 TMEM132E	3.84e-03	13	213	2	C1846647
Disease	Migraine Disorders	TRPM8 PRDM16	3.84e-03	13	213	2	C0149931
Disease	fibromuscular dysplasia	STXBP2 SVIL CARMIL1	3.95e-03	44	213	3	EFO_1000938
Disease	amino acid measurement	DCDC1 GCKR ITGA2 PTPRB NAV3 SYNE1 CARMIL1 GRIK2 ODAD2 MMRN1 PELP1 LRBA	3.99e-03	678	213	12	EFO_0005134
Disease	grip strength measurement	PRSS3 BPTF TECPR2 TNRC6A PRRC2A MAP3K14 OPCML KCTD3	4.08e-03	350	213	8	EFO_0006941
Disease	cholesterol to total lipids in large VLDL percentage	GCKR MYRF APOB	4.21e-03	45	213	3	EFO_0022236
Disease	triglyceride measurement, phospholipid measurement	GCKR BPTF MCUB DMGDH APOB	4.24e-03	146	213	5	EFO_0004530, EFO_0004639
Disease	esterified cholesterol measurement, low density lipoprotein cholesterol measurement	APOB ANKRD17	4.46e-03	14	213	2	EFO_0004611, EFO_0008589
Disease	glycodeoxycholate measurement	SVIL GRIK2	4.46e-03	14	213	2	EFO_0010493
Disease	lysophosphatidylcholine 16:1 measurement	GCKR OPCML	4.46e-03	14	213	2	EFO_0010358
Disease	fatty acid measurement	GCKR BPTF MCUB MYRF DMGDH APOB GRIK2 NFE2L3 CCDC171	4.62e-03	436	213	9	EFO_0005110
Disease	phosphatidylcholine measurement	GCKR ABCC8 MYRF KIF6 APOB GRIK2 OPCML	4.74e-03	284	213	7	EFO_0010226
Disease	triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement	GCKR DMGDH APOB NFE2L3 LRBA	4.75e-03	150	213	5	EFO_0004611, EFO_0020947
Disease	Celiac Disease	TNFRSF14 GBP5 APOB	4.76e-03	47	213	3	C0007570
Disease	Mammary Carcinoma, Human	FASN SYNJ2 SYNE1 DTX3 UBE2C WT1 GRIK2 PALB2 TLE3 GZMB	5.06e-03	525	213	10	C4704874
Disease	Mammary Neoplasms, Human	FASN SYNJ2 SYNE1 DTX3 UBE2C WT1 GRIK2 PALB2 TLE3 GZMB	5.06e-03	525	213	10	C1257931

Protein segments in the cluster

Peptide	Gene	Start	Entry
RTHVIWGTSKDFGIS	ACCSL	386	Q4AC99
LETTVHASGWNKILV	BCL2L13	141	Q9BXK5
GGSLISEDWVVTAAH	CTRB2	61	Q6GPI1
GGSLISQSWVVTAAH	CTRL	61	P40313
IQSQGISSLKVWTSH	PFKFB1	291	P16118
ETVGLWTQAKLESHS	EPG5	1461	Q9HCE0
GLATVKSRWSGSHQF	BRAF	596	P15056
KSRWSGSHQFEQLSG	BRAF	601	P15056
GHWERLASVVSSKTQ	C8orf86	111	Q6ZUL3
TWIIETSHGKGVFFT	CSMD2	951	Q7Z408
LNCTWTVDVTHGKGV	CSMD3	1091	Q7Z407
THGEWELLGLSKATA	HTR3E	211	A5X5Y0
SELTLSHIGVWASGE	ADGRA2	311	Q96PE1
STGNVRTGLWKHETT	ADGRA3	1306	Q8IWK6
FTVSGQWTSGIHKDK	CCDC171	431	Q6TFL3
WGSSINVTLGAHNIK	GZMB	66	P10144
GHWLGLLLSESGSKT	AFAP1L2	436	Q8N4X5
THSERQWQGLSSKGD	ARHGEF16	616	Q5VV41
TVWHTAIEKAAGTDG	ARAP2	1101	Q8WZ64
WELLSQTEHTGAKAA	C8orf58	246	Q8NAV2
KHGNEVSGSTSREVW	LINC00469	61	Q8N7U9
STGGSEWVLEQTIHL	DMXL2	1111	Q8TDJ6
ATWTTLAGSHGKRNN	ANKRD17	1546	O75179
HLQSGSDVVWLDGVS	CD163L1	316	Q9NR16
FTKAHTTSTGLWGLV	HSD11B2	151	P80365
TWKEQTFLSHGALLA	PDSS2	246	Q86YH6
WNGSVHGSKVLTIST	BPTF	891	Q12830
EQLTTSGSGHIKFWE	CFAP44	286	Q96MT7
AHKGSTLSQWSLGNG	ERMP1	806	Q7Z2K6
AEGTLCQTHTIDKGW	ADAMTS10	516	Q9H324
LSAKQLHTLSDTLWG	CA9	351	Q16790
DGLSTNHWLIGTDKC	NAGK	31	Q9UJ70
IWTSSDHQVLSGKTT	CD274	166	Q9NZQ7
TLRGTLKGHNGWVTQ	RACK1	6	P63244
GGSQSSDVVLLNHWK	IMMP2L	51	Q96T52
IWSLAHTATASAVEG	IRX6	351	P78412
SATGNATNSSLIKHW	SLC34A3	261	Q8N130
ATNSSLIKHWCGTTG	SLC34A3	266	Q8N130
HGASTVFLDVSKWTQ	KLHL30	556	Q0D2K2
SWIEQEGVTVKSSSH	ANXA8	6	P13928
NKGALDTHAWSLSGN	MDGA1	856	Q8NFP4
SASTEKQHLEWVGLV	PAPOLB	381	Q9NRJ5
IVLHASVSIGKWSFS	DCDC1	666	M0R2J8
ISTKANSLLISWSHG	PTPRB	211	P23467
NSLLISWSHGSGNVE	PTPRB	216	P23467
WVVTHSGDLSNKVTA	PTPRB	1241	P23467
ILFTVWKHSSGGSSK	OR4F21	221	O95013
FSGSQSGLVHIWSLQ	GNB1L	41	Q9BYB4
AHSEAKTSGLLWAGL	MCUB	211	Q9NWR8
KWTGGAVVSSHKATV	KIAA1671	821	Q9BY89
ESDTGLWLHNKLGAT	NELFA	6	Q9H3P2
LDAATGKSVWGSLAV	NELFE	336	P18615
GAEVKHRNTSSIASW	NCKAP5L	906	Q9HCH0
HTSTSSREGLIQWDK	GPA33	46	Q99795
LTRNGHVIWKGSLTS	MTIF2	661	P46199
EFAAHTWTGQSILTG	FAM149A	736	A5PLN7
TSHKGSLQEVIGWGL	HERC2	416	O95714
SSGSQGKHWIRLEIF	HERC2	2811	O95714
SSLWSGGIGLNNSKH	MMRN1	11	Q13201
AGLSSAIELVSHWTG	HEMK1	36	Q9Y5R4
TWSILHTQGALVQGG	ATRN	486	O75882
GWHLVGNSCLKITTA	ATRN	791	O75882
QQKDSGGLELWHGTS	BMP15	211	O95972
ITHATGIWTANKIVS	CPA5	201	Q8WXQ8
GWDSLTGLLKGTHTA	ERAP1	616	Q9NZ08
ALWVKGQHSTTGKDL	SLC25A17	91	O43808
QREWVTTSGAHKTLV	NEK10	201	Q6ZWH5
SKGWHAVLETNLTGT	PECR	121	Q9BY49
KEWLRSHSTGGLQDT	NAV3	1441	Q8IVL0
VTKDHVWGATTQKTT	FAM205C	301	A6NFA0
TSVDAWLVHSVAAGS	NFE2L3	106	Q9Y4A8
LGWNSRNETSKGNHT	HRH2	156	P25021
WGLHIEDKSTVFGTA	LSS	141	P48449
SGLLVLHWEANGSSS	MEGF8	1381	Q7Z7M0
QHEWSQLLSNKSSGG	KIF6	716	Q6ZMV9
LTDKHGAWGNSAVSR	LRBA	1961	P50851
QKGVISLSLSTHWAE	LCT	1116	P09848
KDGHGTAISNASDVW	LY75	126	O60449
SVASTVQSHTKGIWI	GBP5	66	Q96PP8
SQGKTSQTWHGGIAT	GGCT	56	O75223
HLAKSSGSALTVWGT	GFUS	196	Q13630
LVSGWGTTKSPQVHF	KLK5	186	Q9Y337
SGHLWASLSVKGVKA	LCN10	101	Q6JVE6
DGHTWDIGDVQKLLS	NLRP2	526	Q9NX02
ILSHLGLASKTAAWG	ANXA9	16	O76027
ATNHISGNKIGWEKT	FAM120A	471	Q9NZB2
GGEITAHWLLTNSTT	HEG1	451	Q9ULI3
STLLESHWTKSGENQ	TMEM63A	486	O94886
GAEWSTALSHLVLGV	CYHR1	6	Q6ZMK1
LGAGFSQGLKHTESW	PELP1	246	Q8IZL8
KLNQSGHFLWIGSDS	GRM8	296	O00222
AFGWSGTIVQKTSHG	ITGA2	401	P17301
AGTHQIWALLLDSGK	NHLRC2	361	Q8NBF2
INASHIKVSVSGIEW	PTPN21	951	Q16825
STKWVLNTVSTGAHV	GCKR	481	Q14397
TVTWRHLSVKEGQGF	OPCML	166	Q14982
FVKWSGTDSHLLAGQ	PALB2	1161	Q86YC2
NGTISHIKSITNSVW	CUBN	781	O60494
WNSHTSVGNILGSLI	SLC37A1	196	P57057
ITWNDIHHKTSCTGG	DTX3	306	Q8N9I9
TDGIWSQIKSAGSAL	GMPPA	241	Q96IJ6
TIDAHTNGNGKLALW	APOB	1906	P04114
KTLLKAGHIAWTSSG	APOB	2911	P04114
TLWDSAKGTIHGEEV	CD8B2	71	A6NJW9
TVGHTQRKSGIWSQL	CEFIP	71	Q711Q0
AWIEQEGVTVKSSSH	ANXA8L1	6	Q5VT79
AATWSIKIHNGSSEA	CASD1	166	Q96PB1
ESGTIIFLHNWSKGN	CD1C	61	P29017
TEGELTHLLNSWGVS	EFCAB6	1001	Q5THR3
VGQWTGTELHFTALI	ATPAF1	211	Q5TC12
GSHKRSASWGSTDQL	FAM117B	266	Q6P1L5
TTRISWLHNGKTLDG	CDON	56	Q4KMG0
GVKVLSSSEISVHWE	CNTN1	816	Q12860
NTGWISTLKDLDHET	FAT3	2871	Q8TDW7
QLSSEHGGDVQKWLS	IL2RB	291	P14784
SLKVLSGAWVGFEHA	CRYBA4	46	P53673
HVDAAWGGSVLLSQT	CSAD	271	Q9Y600
VAQGSGTVTFSWHKE	FCRL3	311	Q96P31
KSELTAGSTWHAAGL	DMGDH	81	Q9UI17
VGAWDSKEHLSQATG	LYG2	136	Q86SG7
QWDHTISSLSKAVQG	LAMB4	1181	A4D0S4
KWSTRGSESHELNEG	CARMIL1	1041	Q5VZK9
IQETGSLDKVVSWAH	CYP4B1	61	P13584
STIIAFTSDHGWALG	IDS	326	P22304
THQSGSLALLTGALW	COX15	386	Q7KZN9
TGVKVFSWLATLHGS	MT-CO1	316	P00395
AHWEGLTGRITFNKT	GRIK2	366	Q13002
TSFEQHVLWHTGGKG	FASN	1726	P49327
LNTLTGHTEWVTKVV	FBXW2	261	Q9UKT8
WEVSKINGTHARLST	CDH17	716	Q12864
AGVGKSTLLHKWASG	DIRAS3	46	O95661
LVATSHTGKVGVWNA	KCTD3	291	Q9Y597
GGELSVSTDKSWGLH	PKD1L1	26	Q8TDX9
GGSLISEDWVVTAAH	CTRB1	61	P17538
VDKWSGSIEIGVTTH	NEURL4	371	Q96JN8
TGSNLNDGLWHSVSI	CNTNAP5	441	Q8WYK1
SVSHSQEKEGISNWL	CYP8B1	241	Q9UNU6
SAEGVLHVWGVTTEK	IFNGR1	216	P15260
SQIASVWHGTLSKLL	TBRG4	136	Q969Z0
SHQKGSLPSGTTIEW	OSBPL11	281	Q9BXB4
SSGQAHSLTSLAKTW	MAP3K14	346	Q99558
ILFTVWKHSSGGSSK	OR4F3;	221	Q6IEY1
NGSSIWEVDSLHAKT	KIF13A	961	Q9H1H9
SILAWKSVLGNGHLS	MRPS5	36	P82675
WDSATGTLVKSHLIA	UTP4	221	Q969X6
TANTSGNLSLTWHVK	SUSD2	171	Q9UGT4
HGINIKDRSSTTSTW	CARS2	536	Q9HA77
SKSWLHGSIFGDINS	TMEM71	126	Q6P5X7
QLHITIAVTGWLASG	TMCO4	276	Q5TGY1
WQGRHSTVSEKGTSA	SVIL	1816	O95425
VEIWSGLSSESKLHG	TLL1	676	O43897
AKVLAHGTIAWNSAS	SYNE1	5546	Q8NF91
TLLGTKSRSGQWHVT	TMEM132E	341	Q6IEE7
KSRSGQWHVTSELLT	TMEM132E	346	Q6IEE7
GAKHSTATVDVAWAQ	TMEM132E	361	Q6IEE7
WSLNGHSLSKVFTGS	SYNJ2	431	O15056
KVDSTLIGSSSHVEW	NBPF8	471	Q3BBV2
KVDSTLIGSSSHVEW	NBPF10	506	Q6P3W6
KVDSTLIGSSSHVEW	NBPF11	506	Q86T75
KVDSTLIGSSSHVEW	NBPF14	166	Q5TI25
KVDSTLIGSSSHVEW	NBPF26	166	B4DH59
SGDVSTWKEHLVQAT	ITIH3	326	Q06033
RKLTQWTAAGHGTGI	ODAD2	6	Q5T2S8
STETGKLTQIVFGHW	NBEA	2706	Q8NFP9
QGSLDAWLKVTGATS	PRDM16	1251	Q9HAZ2
GKHTTSSDVWSFGIL	EPHB6	836	O15197
IGSSEWLLSAHKQLT	SMG1	3366	Q96Q15
KEWLRSHSAGGLQDT	NAV2	1531	Q8IVL1
SEAIISTWHKAIAQG	ARHGAP27	596	Q6ZUM4
LWVHGLSKEQTSVSG	SEMG1	166	P04279
LETWGLHFGSQISLT	PIWIL4	431	Q7Z3Z4
PSGVKSWAQASVTHG	PRRC2A	136	P48634
GTFHQWREGTTKSEV	SIGMAR1	131	Q99720
WRGGKAHVNTSQELS	SPATA31E1	811	Q6ZUB1
LWVHGLSKEQASASG	SEMG2	166	Q02383
ETRLGSLHVWGKGTT	SI	1766	P14410
SLHVWGKGTTPVNAV	SI	1771	P14410
SSVHARWIVGKVIGT	MRPS17	6	Q9Y2R5
ASELWAVTHAKILGS	KIAA0753	746	Q2KHM9
GGSLVSEQWVLSAAH	PRSS8	71	Q16651
ILGWHGSKSHSTEQL	OSBPL10	316	Q9BXB5
IWTKDGNLASTLGQH	TBL1XR1	251	Q9BZK7
TALAVGKGLWAEVSS	SPTBN5	941	Q9NRC6
ILFIGWGSQSSKVHI	ABCC8	46	Q09428
SWHKAGNSDSQSIVL	ANKUB1	361	A6NFN9
LLGVEWGGLTHSVTK	APOBR	546	Q0VD83
AEIHGGSLINLTWTA	CLCA1	761	A8K7I4
AWGVAQAEGSSHILT	CNKSR1	671	Q969H4
SAGVDKTTIIWDAHT	TBL1X	346	O60907
LVLSKSQTSVWHGDI	TRIM69	336	Q86WT6
HKSNVLESGDKTGVW	XIRP2	1876	A4UGR9
KTGVWTDTTGEQHLR	XIRP2	1886	A4UGR9
KWIHFGTEVTNSSGR	PITPNM1	966	O00562
GSLESWITAGEHAKE	WFDC3	16	Q8IUB2
NKEGAHSSTFWVLLS	TMTC4	196	Q5T4D3
WATAGLHIGDRTQSK	ZFP92	81	A6NM28
GKDFTWSSTLTVHQR	ZNF876P	181	Q49A33
EKVAHNILSGASWVS	SPART	421	Q8N0X7
FSGEGKNWSSLINLH	VPS13A	1751	Q96RL7
LTLSLHGWTGTGKNF	TOR1A	96	O14656
GTLSGHASWVLNVAF	WDR61	226	Q9GZS3
LGDTFRWKGENVSTH	SLC27A5	551	Q9Y2P5
QEGSVTRLWKAIHTA	TBL3	96	Q12788
GDVSQKTTWHRISVF	SSBP1	76	Q04837
RTNKDLSHTLSWGGN	ZNF774	96	Q6NX45
GHLVSVGWETTLENK	ZNF274	321	Q96GC6
ATEGKWEVLIGSSHI	STXBP2	556	Q15833
ELAIKSWHIIGDGLS	TMEM131	576	Q92545
SLFKGWTGIKENSGH	TMEM131	786	Q92545
WTGIKENSGHRLSAI	TMEM131	791	Q92545
HLSSGEQKGIESDWQ	FGD6	661	Q6ZV73
SVKLGHATFELGATW	SMOX	66	Q9NWM0
LGSSEGWENQTKHTE	ZNF646	131	O15015
TRTWKIVGGVTHANS	TMEM38B	121	Q9NVV0
SSVKWTEGQSNHSTG	WT1	256	P19544
RDWTKQTVGATGHST	TLL2	81	Q9Y6L7
SGGSLSTKSHWASII	ZBED10P	181	Q96FA7
ISWLVGHEGKGSILS	NRDC	461	O43847
DVTGIHKNSITALAW	TECPR2	121	O15040
SGVWISSGKNEFHVA	TECPR2	1086	O15040
EKDLNGSSHWGIIAT	PKD2	371	Q13563
ISHDGTKLWTGGLDN	TLE3	626	Q04726
ISLTNVVGHSLGCTW	PRKRA	201	O75569
SSSGVHLIQAKTAGW	nan	106	Q0VFX4
GGSLISEQWVVSAAH	PRSS3	106	P35030
SSSLSNAKDVAHWLG	SNRNP200	1491	O75643
SLKSHQGVVIASDWL	WDR37	276	Q9Y2I8
HKNITSITNLEGWVG	ZSWIM6	616	Q9HCJ5
NIWSLTSGKSTAIVH	SLC30A4	361	O14863
SWLVTKAGAGTSSSH	TNFRSF14	186	Q92956
IAQSKGAWILTGGTH	TRPM8	171	Q7Z2W7
GKLLLVGGIWIHSSS	LCMT2	596	O60294
GGNLSWHPALTTTSK	ITFG1	186	Q8TB96
GIQLSHVTWSADSKV	WDR35	156	Q9P2L0
HKLGISDVAWSSDSN	WDR5	86	P61964
GKGFSWSSSLIIHQR	ZNF45	646	Q02386
WKHSTGIDIGDSLTI	SLC25A24	166	Q6NUK1
SISLHKSGLQSWEDI	TBCEL	231	Q5QJ74
SINSKVSGGSTHGTW	TNRC6A	406	Q8NDV7
GSVTNTSLAHELWKV	TNRC6A	1706	Q8NDV7
SDNLFKWVGTIHGAA	UBE2C	56	O00762
ATVVGLAWLEHSSAS	VWA5B1	1146	Q5TIE3
KEAESGVIHFTSGIW	ZBED4	721	O75132
AVHKAISQQGTLWTG	MUC12	26	Q9UKN1
KTNLALVVGTHSWRD	SLC8A3	686	P57103
AKSWGLSVNGIGHSK	MYRF	936	Q9Y2G1
HWTTLNGSLPKGVEA	NECTIN1	281	Q15223